Rothrock JF, et al. onabotulinumtoxina is safe and effective in patients who discontinue topiramate: results of the FORWARD Study. Abstract IHC-PO-180. IHC 2019 5-8 sept. Dublin, Ierland.
Vergoeding selumetinib (Koselugo) voor kinderen met neurofibromatose type 1
mei 2024